Back to ONC

BeOne Medicines Ltd. Capital Expenditures 2014-2026 | ONC

Beta

What is capital expenditures?

Capital expenditures (CapEx) can be defined as money spent on acquiring, maintaining, or upgrading physical assets such as property, buildings, and equipment.

What is BeOne Medicines Ltd.'s current capital expenditures?

BeOne Medicines Ltd. (ONC) annual capital expenditures for 2025 was $185.8M, a 62.28% decline from 2024. BeOne Medicines Ltd. capital expenditures for the quarter ending March 31, 2026 was $40.8M.

What was BeOne Medicines Ltd.'s capital expenditures in 2024?

BeOne Medicines Ltd. annual capital expenditures for 2024 was $492.7M, a 12.32% decline from 2023.

What was BeOne Medicines Ltd.'s capital expenditures in 2023?

BeOne Medicines Ltd. annual capital expenditures for 2023 was $561.9M, a 72.66% increase from 2022.

What is BeOne Medicines Ltd.'s 5-year capital expenditures CAGR?

BeOne Medicines Ltd. capital expenditures grew at a compound annual growth rate (CAGR) of 9.60% from FY2020 to FY2025, going from $117.5M to $185.8M over 5 years.

Capital Expenditures History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Declining
CAGR+9.6%
FY2020
$117.5M
→
FY2025
$185.8M
141516171819202122232425
5 years selected
Capital Expenditures History
PeriodValueChangeSource
FY2025$185.8M-62.3%10-K
FY2024$492.7M-12.3%10-K
FY2023$561.9M+72.7%10-K
FY2022$325.4M+23.8%10-K
FY2021$262.9M+123.8%10-K
FY2020$117.5M+31.1%10-K
FY2019$89.6M+27.5%10-K
FY2018$70.3M+51.6%10-K
FY2017$46.4M+97.3%10-K
FY2016$23.5M+342.3%10-K
FY2015$5.3M+712.5%10-K
FY2014$654,000-10-K
Company: BeOne Medicines Ltd.Ticker: ONCSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →